The short answer to our provocative headline is no. But two other recent headlines got us pondering the question. Yesterday, the New York Times, and on Monday, the Journal of the American Medical Association(JAMA) published, respectively, a story and an opinion piece on the potential downsides to medicine that is aimed at specific genetic profiles.Read More
Up at 5AM: The 5AM Solutions Blog
If you’ve been watching the AMC series “Better Call Saul” then you know that Chuck McGill — the older brother of protagonist Jimmy McGill — suffers from a mysterious, and little-understood collection of symptoms described as electromagnetic hypersensitivity (EHS). EHS sufferers report symptoms ranging from headaches to rashes to burning sensations when they are exposed to electromagnetic fields, such as those associated with cell phones.Read More
Personalized medicine is getting a lot of attention these days. In January, President Obama announced that his 2016 budget includes a $215 million investment in precision medicine.Read More
You might remember that back in 2007 and 2008, no publication felt quite right unless it included at least one trend piece about the trendiest scientific and social development of the time: the spit party. Back then, companies like 23andMe were brand new and for less than $500, you could delve into your ancestral genetics, plus get a peek at your genetically encoded health risks and predispositions. After buying a kit online, you would spit into a receptacle, mail it to a lab, and have your results returned in a few weeks.Read More
This is the first in a series of blog posts that will dive more deeply into the nuts and bolts of Data Science. Today we will talk a bit about statistics, but we will be talking tools, visualization strategies, and data representation in the context of specific problems.
From basic research and discovery activities through clinical trial evaluations, the standard collection, processing, storage, and tracking of biospecimens is vital. Genomics, particularly in the context of companion diagnostics, is a key driver for more and better quality biospecimens.
Precision medicine is upon us and it is more than the simple use of information to create drugs and diagnostics that are unique to a single patient. Precision Medicine identifies patients who are more susceptible to certain diseases, who will respond to treatments differently and whose diseases or conditions may progress on a different course than others in the general population.